Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force

A critical overview of the new ATS/ERS guidelines The American Thoracic Society and the European Respiratory Society have jointly issued a new revision of their guidelines for the performance of spirometry, lung volumes, and carbon monoxide transfer factor. These have been published as a series of documents in the European Respiratory Journal .1–5 They contain much wisdom, some compromises, and a few new recommendations. Blood gases, sleep, exercise, and challenge testing have not yet been readdressed. This brief review highlights a few of the more important recommendations dealing with the performance and interpretation of the several tests. This first chapter is essential reading for laboratory staff and sets standards for hygiene, calibration, quality control, and housekeeping. Observance of these standards will reassure research workers as well as clinicians. Peak flow is the topic of current research and the task force plans to introduce more stringent standards for home recording. It may be derived from the flow-volume plot or from a separate blow, ideally using a flow measuring device. The guideline emphasises the importance of rehearsal and the need to blow immediately after a full inspiration. Relaxed expired and inspired vital capacity (EVC and IVC) have been rehabilitated, in spite of the fact that the various COPD guidelines—such as GOLD and others—chose to dispense with them for simplicity. When performing spirometry, the suggested method for EVC is to take the best of three measurements made before the forced expiratory tests, instructing the patient to speed the expiration only at the beginning and end of the blow. There is still no validated standard patter for this test; one suggestion might be “take a full breath in; breathe out gently but firmly”, going on to further encouragement after 2–3 seconds until flow is less than 0.25 l/s. For forced vital capacity …

[1]  K. Shirato,et al.  Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.

[2]  I. Adcock,et al.  Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.

[3]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[4]  P. Enright,et al.  FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace , 2006, European Respiratory Journal.

[5]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[6]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[7]  O. Pedersen FEV6: a shortcut in spirometry? , 2006, European Respiratory Journal.

[8]  R. Crapo,et al.  FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. , 2000, American journal of respiratory and critical care medicine.

[9]  Standardized lung function testing. Report working party. , 1983, Bulletin europeen de physiopathologie respiratoire.

[10]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[12]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[13]  A. Miller,et al.  Standardized lung function testing. , 1984, Bulletin europeen de physiopathologie respiratoire.

[14]  S. Spencer,et al.  Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.

[15]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[16]  N. Anthonisen,et al.  Bronchodilator response in the lung health study over 11 yrs , 2005, European Respiratory Journal.

[17]  B. C. V. Zomeren,et al.  REPORT WORKING PARTY: STANDARDIZATION OF LUNG FUNCTION TESTS , 1983 .

[18]  S. Verbanck,et al.  Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6 , 2006, European Respiratory Journal.

[19]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.